Updated May 8, 2019

House Intel Committee subpoenas DOJ for Mueller report

Reps. Devin Nunes and Adam Schiff. Photo: Drew Angerer/Getty Images

The House Intelligence Committee subpoenaed the Department of Justice on Wednesday evening for "all counterintelligence and foreign intelligence materials in the probe, the full report, and underlying evidence," within the Mueller report, with House Intelligence Chairman Adam Schiff (D-Calif.) tweeting: "We will not be obstructed."

The backdrop: On April 25, Schiff and Ranking Member Devin Nunes (R-Calif.) sent a letter to the Justice Department reiterating their demand for special counsel Robert Mueller to brief the committee about his counterintelligence findings — threatening "compulsory process" if the department does not comply.

"Unfortunately, as the report makes clear, the Department of Justice and the FBI failed to keep the Committee 'fully and currently informed' of this important foreign intelligence and counterintelligence information, as required by law. ...
It is deeply unfortunate, moreover, that the Department and the Bureau failed to respond to the Committee's March 27 request, including to initiate a dialogue to facilitate the production of this information to the Committee and to schedule associated briefings requested in our letter. The Department also failed to respond to the Committee's April 18 request for Special Counsel Mueller to testify before the Committee."

As CNN's Manu Raju notes, the two lawmakers have different motivations for requesting Mueller's counterintelligence information.

  • Schiff is interested in finding out whether Trump or members of his orbit may be compromised by foreign powers.
  • Nunes, a staunch ally of the president, is seeking information for his own probe into potential abuses by the FBI in launching the Russia investigation.
  • Regardless of their reasoning, the letter marks a rare show of bipartisan unity in threatening a subpoena in response to inaction by the Trump administration.

Go deeper

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.

We can't just flip the switch on the coronavirus

Illustration: Sarah Grillo/Axios

It feels like some big, terrible switch got flipped when the coronavirus upended our lives — so it’s natural to want to simply flip it back. But that is not how the return to normalcy will go.

The big picture: Even as the number of illnesses and deaths in the U.S. start to fall, and we start to think about leaving the house again, the way forward will likely be slow and uneven. This may feel like it all happened suddenly, but it won't end that way.

Go deeperArrow23 mins ago - Health

The Fed rescues Wall Street, but Main Street is another story

llustration: Aïda Amer/Axios

In less than a month, the Federal Reserve has unleashed a multi-trillion dollar tour de force to buoy the U.S. economy against the COVID-19 pandemic.

Why it matters: While it has steadied the markets, the Fed is poorly equipped to offset the hit being absorbed by small business owners and the close to 17 million Americans who have filed for unemployment in just the past three weeks.